Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
HEBRON, Ky., May 30, 2018 (GLOBE NEWSWIRE) -- FTJ FundChoice, a national turnkey asset management firm with over $10B assets under administration, has announced an integration with Redtail...
-
SCOTTSDALE, Ariz. and NEWARK, N.J, May 30, 2018 (GLOBE NEWSWIRE) -- Technology-based education start-up Woz U, announced today a partnership with the New Jersey Institute of Technology (NJIT), one...
-
JOPLIN, MISSOURI, May 30, 2018 (GLOBE NEWSWIRE) -- TAMKO Building Products, Inc. is proud to announce that Building Products Inc. (BPI) is distributing Envision® composite decking at their new...
-
INAP selected for presenting growth opportunities strategically aligned with this company’s global expansion plans INAP contracted to provide colocation services and Performance IP to help support...
-
PARSIPPANY, N.J., May 30, 2018 (GLOBE NEWSWIRE) -- Avis, the Official Car Rental Partner of Universal Parks & Resorts, today announced the grand opening of five facilities located at...
-
VANCOUVER, British Columbia, May 30, 2018 (GLOBE NEWSWIRE) -- NeutriSci International Inc. ("NeutriSci") (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer behind neuenergy®, and...
-
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- NYI, a leading provider of customized hybrid infrastructure solutions and managed services, announces its partnership with IT Creations, an enterprise...
-
京都および大阪発, May 30, 2018 (GLOBE NEWSWIRE) -- 標的放射性医薬品または「分子標的放射線」 (MTR) ベースの診断用･治療用製品の開発に注目するオーストラリアのバイオ製薬会社であるテリックス･ファーマシューティカルズ (Telix Pharmaceuticals Limited、ASX.TLX、以下「テリックス」または「同社」)...
-
MINNEAPOLIS, May 29, 2018 (GLOBE NEWSWIRE) -- Fishing League Worldwide (FLW), the world’s largest tournament-fishing organization, today announced the renewal of its global partnership with T-H...
-
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...